Daniela Guilliam, MD
Sleep Medicine · Austell, GANPI 1245487800
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 39.6% of the total.
Across 77 payments — averaging $33.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- Harmony Biosciences LLC$376
- Jazz Pharmaceuticals Inc.$167
- Sanofi$155
- Boehringer Ingelheim$126
- EMD Serono, Inc.$126
- plus $618 from 20 others
What the payments were for
- Food & beverage$2,49696%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 9 | $1,028 |
| Harmony Biosciences LLC | 14 | $376 |
| Jazz Pharmaceuticals Inc. | 6 | $167 |
| Sanofi | 5 | $155 |
| Boehringer Ingelheim | 6 | $126 |
| EMD Serono, Inc. | 7 | $126 |
| AbbVie(2 entities) | 5 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| Insmed, Inc. | 2 | $46 |
| Baxter Healthcare | 2 | $44 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $41 |
| Verona Pharma, Inc. | 1 | $39 |
| GE HealthCare | 2 | $34 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
| Pulmonx Corporation | 1 | $28 |
| Merck | 1 | $27 |
| Amgen | 1 | $23 |
| Stryker | 1 | $22 |
| Mallinckrodt Enterprises LLC | 1 | $22 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Novartis | 1 | $16 |
| GSK | 1 | $16 |
| Resmed Corp | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,596 in reported general payments places this provider in the 55th percentile of 50 sleep medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxepin Hcl | 15 | $1,967 |
| Temazepam | 14 | $229 |
| Trazodone Hcl | 38 | $222 |
| Gabapentin | 44 | $222 |
| Amitriptyline Hcl | 16 | $129 |
| Ropinirole Hcl | 19 | $50 |
| Tizanidine Hcl | 12 | $44 |
| Zolpidem Tartrate | 25 | $28 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Austell
- Justin ParkAustell$2K
- Murad AssaadAtlanta$139K
- Nancy CollopAtlanta$28K
- Scott LeibowitzAtlanta$22K
- Anuj ChandraTrenton$20K
- Chantale BransonAtlanta$17K
- Melissa RhodesCartersville$14K
- James DalySavannah$12K
- Romy HoqueAtlanta$10K
- Naseer HumayunDalton$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.